194
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Effect of Level of Dietary Zilpaterol Hydrochloride (β2-agonist) on Performance, Carcass Characteristics and Visceral Organ Mass in Hairy Lambs Fed All-concentrate Diets

, , , , , & show all
Pages 33-38 | Received 05 Jan 2010, Accepted 25 Jun 2010, Published online: 14 Nov 2011
 

Abstract

Ríos Rincón, F.G., Barreras-Serrano, A., Estrada-Angulo, A., Obregón, J.F., Plascencia-Jorquera, A., Portillo-Loera, J.J. and Zinn, R.A. 2010. Effect of level of dietary zilpaterol hydrochloride (β2-agonist) on performance, carcass characteristics and visceral organ mass in hairy lambs fed all-concentrate diets. J. Appl. Anim. Res., 38: 33–38.

To evaluate the influence of zilpaterol (β2-agonist) supplementation level on growth performance, energy retention, carcass characteristics and visceral organ mass lambs were fed a dry-rolled corn-based finishing diet supplemented with 0, 0.12 or 0.18 mg/kg BW d−1 zilpaterol hydrochloride. Zilpaterol supplementation increased carcass adjusted daily gain (40.0%, P<0.03), gain efficiency (28.2%, P<0.03), apparent energy retention per unit DMI (13.0%, P = 0.04), carcass weight (6.9%, P = 0.01), dressing percentage (2.3%, P<0.05) and reduced kidney-pelvic fat (11.4%, P = 0.02), liver weight (g/kg final EBW; 9.5%, P = 0.01) and mesenteric fat (18.6%, P<0.01). It is concluded that, zilpaterol supplementation increase growth performance and dressing percentage in lambs as results of greater muscle accretion and for reduction of visceral organ mass and body fat. Although response to zilpaterol supplementation could be observed since 0.12 mg of zilpaterol/kg BW d−1, feed efficiency and apparent energy retention per unit of DMI tended to be greater when zilpaterol was supplemented at rate of 0.18 mg of zilpaterol/kg BW d−1.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.